Poland· PL-100455915
Ryeqo
A relugolix, estradiol und norethisteron product containing relugolixum + estradiolum + norethisteroni acetas, registered in Poland by Gedeon Richter Plc.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Relugolix, estradiol und norethisteron is registered in 11 of 19 countries.
Countries holding a registration under ATC H01CC54 (relugolix, estradiol und norethisteron), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Relugolix, estradiol und norethisteron · ATC H01CC54
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Relugolixum + Estradiolum + Norethisteroni acetas
- Manufacturer
- Gedeon Richter Plc.
- Country
- Poland (PL)
- ATC code
- H01CC54
- ATC class
- Relugolix, Estradiol und Norethisteron
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
1 priced- gtin0599700137794928 szt.PLN 353
- gtin05997001370742
- gtin05997001371824
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Relugolix, estradiol und norethisteron in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandRyeqo, FilmtablettenGedeon Richter (Schweiz) AG
- NorwayRyeqo2care4 ApS
- CanadaMYFEMBREESUMITOMO PHARMA SWITZERLAND GMBH
- NetherlandsRyeqo 40 mg/1 mg/0.5 mg, filmomhulde tablettenGedeon Richter Plc
- SwedenRyeqo 40 mg/1 mg/0,5 mg Filmdragerad tablettGedeon Richter Plc
- United KingdomRyeqo 40mg/1mg/0.5mg tabletsGedeon Richter (UK) Ltd
- SpainRYEQO 40 MG/1 MG/0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGedeon Richter Plc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ryeqo
- Liechtenstein · Ryeqo
- Norway · Ryeqo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52ccdaed-948b-4fad-8581-0acd440ad8e2 GET /v1/drugs/52ccdaed-948b-4fad-8581-0acd440ad8e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "40 mg + 1 mg + 0,5 mg",
"packaging": "05997001370742 ¦ Rp ¦ EU/1/21/1565/001 ¦ 141320\n28 tabl. w butelce\nRp ¦ EU/1/21/1565/002 ¦ 148443\n84 tabl. w butelce\n05997001371824 ¦ Rp ¦ EU/1/21/1565/004 ¦ 153270\n84 tabl. w blistrze\n05997001377949 ¦ Rp ¦ EU/1/21/1565/003 ¦ 153271\n28 tabl. w blistrze",
"substance": "Relugolixum 40 mg + Estradiolum 1 mg + Norethisteroni acetas 0.5 mg",
"common_name": "Relugolixum + Estradiolum + Norethisteroni acetas",
"pl_product_id": "100455915",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about relugolix, estradiol und norethisteron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.